US Retail Sales Rise 0.8% as Gas Prices Lift September Spending
US retail sales rose 0.8% in September on a gasoline surge, while core spending slowed and producer prices jumped 1.3%, raising rate-hike bets.
Chip and AI Infrastructure Stocks Sink on High Rates and Debt Concerns
Rising borrowing costs and an AI stock rout push Firmus to scrap its $5B Australian IPO for a private round.
Producer Prices Post Biggest Monthly Gain Since March 2022
US producer prices jumped 1.3% in September, the largest monthly rise since March 2022, as energy costs surged 10.8% amid Middle East oil supply curbs.
-400x300.webp)
Inflation Is Heating Up Again. Wall Street Is Finding Shelter in These Stocks
September CPI rose 0.6% with gasoline driving the jump, reviving October Fed hike odds and lifting demand for dividend-paying stocks.
Big Pharma Is Back in Favor on Wall Street. Here's Where the Growth Is
Lilly, AbbVie and Merck post strong Q2 2026 results as healthcare leads defensive buying after hot inflation data, though growth rests on few drugs.
Berkshire Buys $330M More of Bending Spoons in Private Placement
Berkshire Hathaway Adds $330M to Bending Spoons Lifting Its Stake to 4%
Premarket Movers: Liquidia Surges on Legal Settlement, Bank of America Falls
Premarket Movers: Liquidia Surges on Legal Settlement, Bank of America Falls
-400x300.webp)
LVMH's Recovery Is Stalling. Why Wall Street Isn't Rushing to Buy Luxury Stocks
Luxury Stocks Look Cheap and That's Exactly Why Bargain Hunters Should Wait
UnitedHealth's Turnaround Has Wall Street Looking Past Its Biggest Problems
UnitedHealth beat third-quarter estimates on lower medical costs, raised its full-year outlook, and shed members as managed care margins recover.
Johnson & Johnson Beats Q3 Estimates, Raises Sales Outlook
Johnson & Johnson beat third-quarter revenue and EPS estimates, raised full-year guidance, and saw Tremfya growth offset Stelara losses as MedTech lagged.
Barclays Is Betting on a Defense Shake-Up. These Stocks Could Come Out Ahead
Barclays initiates US aerospace and defense coverage with Overweight ratings on six stocks, favoring defense tech firms over legacy primes.
